255 related articles for article (PubMed ID: 23576578)
41. beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation.
Tohgo A; Pierce KL; Choy EW; Lefkowitz RJ; Luttrell LM
J Biol Chem; 2002 Mar; 277(11):9429-36. PubMed ID: 11777902
[TBL] [Abstract][Full Text] [Related]
42. Angiotensin II increases expression of cyclooxygenase-2: implications for the function of vascular smooth muscle cells.
Hu ZW; Kerb R; Shi XY; Wei-Lavery T; Hoffman BB
J Pharmacol Exp Ther; 2002 Nov; 303(2):563-73. PubMed ID: 12388637
[TBL] [Abstract][Full Text] [Related]
43. Angiotensin II enhances interleukin-18 mediated inflammatory gene expression in vascular smooth muscle cells: a novel cross-talk in the pathogenesis of atherosclerosis.
Sahar S; Dwarakanath RS; Reddy MA; Lanting L; Todorov I; Natarajan R
Circ Res; 2005 May; 96(10):1064-71. PubMed ID: 15860756
[TBL] [Abstract][Full Text] [Related]
44. Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors.
Wolf G; Wenzel U; Burns KD; Harris RC; Stahl RA; Thaiss F
Kidney Int; 2002 Jun; 61(6):1986-95. PubMed ID: 12028439
[TBL] [Abstract][Full Text] [Related]
45. Induction of cyclooxygenase-2 by angiotensin II in cultured rat vascular smooth muscle cells.
Ohnaka K; Numaguchi K; Yamakawa T; Inagami T
Hypertension; 2000 Jan; 35(1 Pt 1):68-75. PubMed ID: 10642277
[TBL] [Abstract][Full Text] [Related]
46. The arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1-B2 receptor heterodimers.
Wilson PC; Lee MH; Appleton KM; El-Shewy HM; Morinelli TA; Peterson YK; Luttrell LM; Jaffa AA
J Biol Chem; 2013 Jun; 288(26):18872-84. PubMed ID: 23661707
[TBL] [Abstract][Full Text] [Related]
47. Tumor necrosis factor receptor-associated factor-6 and ribosomal S6 kinase intracellular pathways link the angiotensin II AT1 receptor to the phosphorylation and activation of the IkappaB kinase complex in vascular smooth muscle cells.
Doyon P; Servant MJ
J Biol Chem; 2010 Oct; 285(40):30708-18. PubMed ID: 20659889
[TBL] [Abstract][Full Text] [Related]
48. Bcr kinase activation by angiotensin II inhibits peroxisome-proliferator-activated receptor gamma transcriptional activity in vascular smooth muscle cells.
Alexis JD; Wang N; Che W; Lerner-Marmarosh N; Sahni A; Korshunov VA; Zou Y; Ding B; Yan C; Berk BC; Abe J
Circ Res; 2009 Jan; 104(1):69-78. PubMed ID: 19023129
[TBL] [Abstract][Full Text] [Related]
49. β-Arrestin 1 is required for endothelin-1-induced NF-κB activation in ovarian cancer cells.
Cianfrocca R; Tocci P; Semprucci E; Spinella F; Di Castro V; Bagnato A; Rosanò L
Life Sci; 2014 Nov; 118(2):179-84. PubMed ID: 24530737
[TBL] [Abstract][Full Text] [Related]
50. TGF-beta inhibits Ang II-induced MAPK p44/42 signaling in vascular smooth muscle cells by Ang II type 1 receptor downregulation.
Meijering BD; van der Wouden EA; Pelgröm V; Henning RH; Sharma K; Deelman LE
J Vasc Res; 2009; 46(5):459-68. PubMed ID: 19204403
[TBL] [Abstract][Full Text] [Related]
51. Stable interaction between beta-arrestin 2 and angiotensin type 1A receptor is required for beta-arrestin 2-mediated activation of extracellular signal-regulated kinases 1 and 2.
Wei H; Ahn S; Barnes WG; Lefkowitz RJ
J Biol Chem; 2004 Nov; 279(46):48255-61. PubMed ID: 15355986
[TBL] [Abstract][Full Text] [Related]
52. High sodium augments angiotensin II-induced vascular smooth muscle cell proliferation through the ERK 1/2-dependent pathway.
Liu G; Hitomi H; Rahman A; Nakano D; Mori H; Masaki T; Ma H; Iwamoto T; Kobori H; Nishiyama A
Hypertens Res; 2014 Jan; 37(1):13-8. PubMed ID: 24026042
[TBL] [Abstract][Full Text] [Related]
53. Receptor/beta-arrestin complex formation and the differential trafficking and resensitization of beta2-adrenergic and angiotensin II type 1A receptors.
Anborgh PH; Seachrist JL; Dale LB; Ferguson SS
Mol Endocrinol; 2000 Dec; 14(12):2040-53. PubMed ID: 11117533
[TBL] [Abstract][Full Text] [Related]
54. PPARgamma agonist, rosiglitazone, regulates angiotensin II-induced vascular inflammation through the TLR4-dependent signaling pathway.
Ji Y; Liu J; Wang Z; Liu N; Gou W
Lab Invest; 2009 Aug; 89(8):887-902. PubMed ID: 19451898
[TBL] [Abstract][Full Text] [Related]
55. Phosphorylation of C3a receptor at multiple sites mediates desensitization, β-arrestin-2 recruitment and inhibition of NF-κB activity in mast cells.
Gupta K; Subramanian H; Klos A; Ali H
PLoS One; 2012; 7(10):e46369. PubMed ID: 23077507
[TBL] [Abstract][Full Text] [Related]
56. Role of matrix Gla protein in angiotensin II-induced exacerbation of vascular calcification.
Jia G; Stormont RM; Gangahar DM; Agrawal DK
Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H523-32. PubMed ID: 22796540
[TBL] [Abstract][Full Text] [Related]
57. Global phosphorylation analysis of beta-arrestin-mediated signaling downstream of a seven transmembrane receptor (7TMR).
Xiao K; Sun J; Kim J; Rajagopal S; Zhai B; Villén J; Haas W; Kovacs JJ; Shukla AK; Hara MR; Hernandez M; Lachmann A; Zhao S; Lin Y; Cheng Y; Mizuno K; Ma'ayan A; Gygi SP; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15299-304. PubMed ID: 20686112
[TBL] [Abstract][Full Text] [Related]
58. O-Linked β-N-Acetylglucosamine Modification of A20 Enhances the Inhibition of NF-κB (Nuclear Factor-κB) Activation and Elicits Vascular Protection After Acute Endoluminal Arterial Injury.
Yao D; Xu L; Xu O; Li R; Chen M; Shen H; Zhu H; Zhang F; Yao D; Chen YF; Oparil S; Zhang Z; Gong K
Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1309-1320. PubMed ID: 29622561
[TBL] [Abstract][Full Text] [Related]
59. RhoGDI stability is regulated by SUMOylation and ubiquitination via the AT1 receptor and participates in Ang II-induced smooth muscle proliferation and vascular remodeling.
Dai F; Qi Y; Guan W; Meng G; Liu Z; Zhang T; Yao W
Atherosclerosis; 2019 Sep; 288():124-136. PubMed ID: 31362179
[TBL] [Abstract][Full Text] [Related]
60. Angiotensin II induces monocyte chemoattractant protein-1 expression via a nuclear factor-kappaB-dependent pathway in rat preadipocytes.
Tsuchiya K; Yoshimoto T; Hirono Y; Tateno T; Sugiyama T; Hirata Y
Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E771-8. PubMed ID: 16705055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
